Today, the U.S. Department of Health and Human Services published a new Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics - PDF. Individual patients, as well as the health [...]
The American Medical Association (AMA) continues to express its concerns over Walmart's corporate prescription opioid restriction policy in its recent letter to Walmart's Chief Medical and Analytics Officer. The new policy limit opioid prescriptions to seven [...]
AAPM members have asked about the impact on their practices of the CMS proposal for opioid treatment services. Starting January 1, 2020 the Centers for Medicare & Medicaid Services (CMS) plans to pay Opioid Treatment [...]
CDC Media Statement: CDC today announced the updated number of confirmed and probable cases of lung injury and deaths associated with e-cigarette product use, or vaping. Full story.
The new, minimally invasive procedure developed by University at Buffalo researchers utilizes delivery of an antibody that targets and thus blocks the pro-inflammatory protein called tumor necrosis factor-alpha (TNF), specifically in the brain.Full story.
This article provides additional information on the background and processes used to value services in the Proposed Rule for the 2020 Physician Fee Schedule, including the advocacy efforts with CMS and RUC by AAPM and [...]
AAPM members Magdalena Anitescu, MD, PhD, Madhuri Are, MD, Samer Narouze, MD, PhD, and Dennis J Patin, MD, are featured in this U.S. News and World Reports article: A Patient's Guide to Pain Management.Full [...]
AAPM member Beth Darnall, PhD, recently spoke at the annual meeting of the Patient-Centered Outcomes Research Institute about tapering opioids and the EMPOWER (Effective Management of Pain and Opioid-Free Ways to Enhance Relief) study [...]
AAPM member Chester "Trip" Buckenmaier III, MD, comments on the DoD's new pain rating scale that bears the familiar 0-10 numbers, smiley and frowny faces and green, amber and red stoplight colors meant to signal [...]
The new, minimally invasive procedure developed by University at Buffalo researchers utilizes delivery of an antibody that targets and thus blocks the pro-inflammatory protein called tumor necrosis factor-alpha (TNF), specifically in the brainFull story.
© American Academy of Pain Medicine. All Rights Reserved | Privacy Policy | Media Resources
American Academy of Pain Medicine (AAPM) is a nonprofit 501(c)(6) tax-exempt organization.
